Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Halfmann

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Immunity|May 22, 2021
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targetsHaley L Dugan, Christopher T Stamper, Lei Li, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Cell Reports|April 4, 2025
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike proteinSharon L Schendel, Xiaoying Yu, Peter J Halfmann, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Immunity|May 22, 2021
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targetsHaley L Dugan, Christopher T Stamper, Lei Li, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Cell Reports|April 4, 2025
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike proteinSharon L Schendel, Xiaoying Yu, Peter J Halfmann, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Cell|August 11, 2018
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to ProtectionErica Ollmann Saphire, Sharon L Schendel, Marnie L Fusco, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Nature|January 11, 2022
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, John E Bowen, Laura E Rosen, et al.
Biorxiv : the Preprint Server for Biology|December 21, 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftElisabetta Cameroni, Christian Saliba, John E Bowen, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 12